As expected, RNH1 expression in BLCA was positively correlated with the expression of multiple immune checkpoints, such as PD-L1, CD80, CD86, HAVCR2, IDO1, LAG3, LAIR1, and PD-1 (Fig. 6C). Here, CD86 is linked to bladder transitional cell carcinoma.